LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

2.77 2.21

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.64

Max

2.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

30M

-21M

Verkäufe

35M

480M

Gewinnspanne

-4.351

Angestellte

4,500

EBITDA

512K

15M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+186.74% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

24. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-456M

324M

Vorheriger Eröffnungskurs

0.56

Vorheriger Schlusskurs

2.77

Nachrichtenstimmung

By Acuity

63%

37%

309 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Feb. 2026, 22:31 UTC

Ergebnisse

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18. Feb. 2026, 22:18 UTC

Ergebnisse

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18. Feb. 2026, 22:11 UTC

Ergebnisse

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18. Feb. 2026, 21:52 UTC

Ergebnisse

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18. Feb. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18. Feb. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18. Feb. 2026, 23:34 UTC

Market Talk
Ergebnisse

Brambles' Cost Control Stands Out to Bull -- Market Talk

18. Feb. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18. Feb. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18. Feb. 2026, 22:45 UTC

Ergebnisse

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18. Feb. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18. Feb. 2026, 22:37 UTC

Ergebnisse

Nutrien 4Q EPS $1.18 >NTR.T

18. Feb. 2026, 22:37 UTC

Ergebnisse

Nutrien 4Q Sales $5.34B >NTR.T

18. Feb. 2026, 22:35 UTC

Ergebnisse

Pan American Silver 4Q EPS $1.07 >PAAS

18. Feb. 2026, 22:35 UTC

Ergebnisse

Pan American Silver 4Q Rev $1.18B >PAAS

18. Feb. 2026, 22:30 UTC

Ergebnisse

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18. Feb. 2026, 22:29 UTC

Ergebnisse

Kinross Gold 4Q EPS 75c >K.T

18. Feb. 2026, 22:22 UTC

Ergebnisse

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18. Feb. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18. Feb. 2026, 22:16 UTC

Ergebnisse

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18. Feb. 2026, 22:05 UTC

Ergebnisse

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18. Feb. 2026, 22:03 UTC

Ergebnisse

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18. Feb. 2026, 22:02 UTC

Ergebnisse

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18. Feb. 2026, 22:02 UTC

Ergebnisse

Kaiser Aluminum 4Q Sales $929M >KALU

18. Feb. 2026, 22:02 UTC

Ergebnisse

Kaiser Aluminum 4Q EPS $1.68 >KALU

18. Feb. 2026, 22:00 UTC

Ergebnisse

Kinross Gold 4Q Adj EPS 67c >KGC

18. Feb. 2026, 22:00 UTC

Ergebnisse

Kinross Gold 4Q Sales $2.02B >KGC

18. Feb. 2026, 21:56 UTC

Ergebnisse

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

186.74% Vorteil

12-Monats-Prognose

Durchschnitt 8 USD  186.74%

Hoch 10 USD

Tief 5 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

6

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

309 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat